Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 23.16 -0.28 (1.19%)
Previous Close $23.44    52 Week High $12.48 
Open $23.33    52 Week Low $1.60 
Day High $23.56    P/E N/A 
Day Low $22.88    EPS $-6.33 
Volume 389,565